Objective. Th e aim of the present study was to investigate the eff ect of hypoxia on the expression of genes encoding insulin-like growth factors (IGF1 and IGF2), their receptor (IGF1R), binding protein-4 (IGFBP4), and stanniocalcin 2 (STC2) in U87 glioma cells in relation to inhibition of endoplasmic reticulum stress signaling mediated by IRE1 (inositol requiring enzyme 1) for evaluation of their possible signifi cance in the control of tumor growth.
Insulin-like growth factors (IGFs, IFG1 and IGF2) are secreted factors playing an important role in the regulation of numerous metabolic and proliferative processes, including tumorigenesis and metabolic diseases such are obesity and diabetes, through interaction with specifi c cell surface receptors (IGF receptor, and hybrid IGF1/insulin (INS) receptor (Pollak 2008; Ohlsson et al. 2009; Halje et al. 2012; Panda et al. 2013; Girnita et al. 2014 ). IGF1 as well as IGF2 are protein hormones that have been shown to exert several biological functions in multiple biological systems in cell proliferation, growth, migration, diff erentiation, and survival regulations. Th us, IGF-2 induction of aryl hydrocarbon receptor in MCF-7 breast cancer cells promotes the expression of CCND1 and the proliferation of these cells (Tomblin and Salisbury 2014) . It is interesting to note that apoptosis can also be regulated via IGF1 receptor (Pan et al. 2014) . Th ere exists a specifi c cross talk between signaling pathways mediated by IGF and INS receptor both at the receptor and downstream signaling levels in tissue specifi c manner depending on the insulin receptor isoform (Limesand et al. 2013) . Furthermore, formation of hybrid receptor isoforms between receptors for IGF1 and insulin as well as hybrid receptors of IGF1/INS receptor with other tyrosine kinase potentiate the transformation of cells, tumorigenesis, and tumor neovascularization (Weroha and Haluska 2012; Dai et al. 2013; Baxter 2014; Singh et al. 2014; Zhu et al. 2014) . Moreover, insulin system including ligands (insulin and IGFs) and their shared receptors (INS/IGF receptors) are critical regulators of insulin signaling and glucose homeostasis (Philippou et al. 2014; Singh et al. 2014) .
Th e insulin-like growth factor binding proteins (IGFBPs) bind and regulate the availability of both IGFs and inhibit or stimulate the growth promoting eff ects of the IGFs through IGF/INS receptors. Th rough other signaling pathways, they also regulate cell proliferation and survival as well as tumor angiogenesis and cancer cell migration (Duan et al. 2010; Azar et al. 2011; Baxter 2014; Zhu et al. 2014) . IGFBPs have been understood to have many actions beyond their endocrine role in the transport of IGF (Baxter 2014; Zhu et al. 2014) . IGFBP4 preferentially binds2 to IGF2 and has IGF-independent eff ects, including inhibition of angiogenesis and promotion of cancer cell migration (Praveen Kumar et al. 2014) . In addition to interaction of IGFBPs with their canonical ligands (IGF1 and IGF2), they can also play an important role in the regulation of various processes including transcription, because they can interact with many proteins (Ingermann et al. 2010; Baxter 2014; Ellis et al 2014) . IGFBP4 regulates growth and development of tissues and organs by negatively regulating the IGF signaling. Among most cancers, IGFBP4 also has a growth inhibitory role. It has been reported as a down-regulated gene, except in renal cell carcinoma and some gliomas, wherein it promotes tumor progression (Praveen Kumar et al. 2014) . Th us, IGFBP4 modulates ligand-dependent estrogen receptor-alpha activation in breast cancer cells in an IGF-independent manner via activation of the Akt/PKB signaling pathway (Hermani et al. 2013) . Recently, it has been shown that inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP4, an important negative regulator of IGF-1 signaling, leading to reduced melanoma growth and angiogenesis in vivo (Contois et al. 2015) .
Th e expression of IGFs, their receptors, and binding proteins are regulated at transcription and posttranscriptional levels (Panda et al. 2013) . Moreover, the eff ect of IGF1 in the regulation of tumor cell growth depends on its mRNA splicing and posttranslational modifi cations, such as proteolytic processing and glycosylation (Philippou et al. 2014; Halje et al. 2012) . Recently, it has been shown that a long non-coding RNA responsive to IGF/INS signaling (CRNDE) regulates genes involved in central metabolism processes (Ellis et al. 2014) and that platelet-released miR-223 promotes advanced glycation end product-induced vascular endothelial cell apoptosis via targeting insulin-like growth factor 1 receptor (Pan et al. 2014) . It is interesting to note that protein kinase LKB1 expression in cancer cell may result in dephosphorylation of several tumor-enhancing RTKs, including ErbB2, hepatocyte growth factor receptor (c-Met), and IGF1R (Okon et al. 2014) . Th ere are also data indicating that liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP phosphorylation in fetal growth restriction (Abu Shehab et al. 2014) .
IGFs, their receptors and IGFBPs participate in endoplasmic reticulum (ER) stress, which is an important factor of cancer growth, insulin resistance, and obesity (Cao and Kaufman 2013; Minchenko et al. 2013b; Han and Kaufman 2014; Lee and Ozcan 2014; Wang and Kaufman 2012; Yadav et al. 2014; Chevet et al. 2015; Minchenko et al. 2015a,b) . Th e endoplasmic reticulum is a dynamic intracellular organelle with exquisite sensitivity to alterations in homeostasis responsible for multiple cellular functions including protein folding and the maintenance of cellular homeostasis and provides stringent quality control systems to ensure that only correctly folded proteins transit to the Golgi and unfolded proteins are ulti-mately degraded (Maurel et al. 2014a) . It is interesting to note that secreted proteinase inhibitor stanniocalcin 2 (STC2) is a novel extracellular component of the IGF system, which potently inhibits the proteolytic activity of the growth-promoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A) and prevents cleavage of IGFBP4 (Jepsen et al. 2015) .
Th e ER stress is mediated by three sensors and signaling pathways, but IRE1 is a central mediator of the unfolded protein response and an important component of tumor growth. Its blockade leads to suppression of a tumor growth through down-regulation of the angiogenesis and proliferation processes (Drogat et al. 2007; Auf et al. 2010 Auf et al. , 2013 . Th is stress is recognized as an important determinant of cancer, obesity, and type 2 diabetes. It may contribute to the expression profi le of many regulatory genes resulting in proliferation, apoptosis, angiogenesis, and peripheral insulin resistance (Minchenko et al. 2013b; Clarke et al. 2014; Han and Kaufman 2014; Manie et al. 2014; Minchenko et al. 2015a) . Two distinct catalytic domains of the signaling enzyme IRE1 (protein kinase and endoribonuclease) are responsible for degradation of a specifi c subset of mRNA and alternative splicing of the XBP1 (X-box binding protein 1) transcription factor mRNA for control of the expression of unfolded protein response-specifi c genes (Acosta-Alvear et al. 2007; Aragon et al. 2009; Auf et al. 2010; Dejeans et al. 2012; Han et al. 2013; Pluquet et al. 2013; Maurel et al. 2014b) .
Th e ER stress response-signaling pathway is tightly associated with hypoxia and linked to the neovascularization, tumor growth, and cell death processes as well as to suppression of insulin receptor signaling through activation of c-Jun N-terminal kinase (JNK) and subsequent serine phosphorylation of IRS1 (Langlais et al. 2011; Lenihan and Taylor 2013; Clarke et al. 2014; Minchenko et al. 2014) . Th e ER has an essential position as a signal integrator because the signaling pathways elicited by ER stress sensors have connections with metabolic pathways and with other plasma membrane receptor signaling networks (Bravo et al. 2013; Cao and Kaufman, 2013; Han et al. 2013; Clarke et al. 2014; Manie et al. 2014) . Th ere are data indicating that hypoxia may aff ect the expression of most INS and IGF related genes in IRE1 dependent manner (Minchenko et al. 2013b (Minchenko et al. , 2015a . It has been also shown that hypoxia in children decreases the level of IGF1 and IGF2 proteins in plasma (Custodio et al. 2012) .
Th e main goal of this work was to study the role of expression of genes encoding the IGF1, IGF2, and their receptor (IGF1R) as well as IFG binding protein-4 and stanniocalcin 2 (STC2) in U87 glioma cell line and its subline with IRE1 loss of function upon hypoxia for evaluation of its possible signifi cance in the control of tumor growth through IRE1 mediated ER stress signaling.
Materials and Methods
Cell lines and culture conditions. Th e glioma cell line U87 was obtained from ATCC (U.S.A.) and grown in high glucose (4.5 g/l) Dulbecco's modifi ed Eagle's minimum essential medium (Gibco, Invitrogen, Carlsbad, CA, U.S.A.) supplemented with glutamine (2 mM), 10% fetal bovine serum (EquitechBio, Inc., U.S.A.), penicillin (100 units/ml; Gibco) and streptomycin (0.1 mg/ml; Gibco) at 37 o C in a 5% CO 2 incubator. In this work, we used two sublines of this glioma cells. One subline was obtained by selection of stable transfected clones with overexpression of vector pcDNA3.1, which was used for creation of dn-IRE1. Th is untreated subline of glioma cells (control glioma cells) was used as control 1 in the study of the eff ect of hypoxia on the expression level of diff erent IGF and related genes. Second subline was obtained by selection of stable transfected clone with overexpression of IRE1 dominant/negative construct (dnIRE1) and has suppressed both protein kinase and endoribonuclease activities of this signaling enzyme (Auf et al. 2010) . Th e expression level of studied genes in these cells was compared with cells, transfected by vector (control 1), but this subline was also used as control 2 for investigation the eff ect of hypoxia on gene expressions under blockade of both enzymatic activities of IRE1. Th e effi ciency of IRE1 suppression in this glioma cell subline has been estimated previously (Minchenko et al. 2013b; Auf et al. 2010 Auf et al. , 2013 by determining the expression level of the XBP1 alternative splice variant, a key transcription factor in the IRE1 signaling, and the level of the phosphorylated isoform IRE1 using cells treated by tunicamycin (0.01 mg/ml during 2 h). Both sublines of glioma cells used in this study are grown with the addition of geneticin (G418) while these cells carrying empty vector pcDNA3.1 or dn-ERN1 construct.
Hypoxic condition was created in special incubator with 3% oxygen and 5% carbon dioxide levels; culture plates with complete DMEM were exposed to these conditions for 16 h.
RNA isolation. Total RNA was extracted from glioma cells using the Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.). RNA pellets was washed with 75% ethanol and dissolved in nuclease-free water. For additional purifi cation RNA samples were re-precipitated with 95% ethanol and re-dissolved again in nuclease-free water. RNA concentration and spectral characteristics were measured using NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative PCR analysis. Th e expression levels of insulin-like growth factors (IGF1 and IGF2), IGF1 receptor (IGF1R), IGF binding protein-4 (IGFBP4), and stanniocalcin 2 (STC2) mRNAs as well as ACTB mRNA were measured in control U87 glioma cells and cells with a defi ciency of IRE1 by quantitative polymerase chain reaction in real-time using qPCR "RotorGene RG-3000" (Corbett Research, Germany) and SYBRGreen Mix (ABgene, Th ermo Fisher Scientifi c, Epsom, Surrey, UK). QuaniTect Reverse Transcription Kit (QIA-GEN, Hilden, Germany) was used for cDNA synthesis as described previously (Minchenko et al. 2012) . Polymerase chain reaction was performed in triplicate.
For amplifi cation of IGF1 cDNA, we used forward (5'-catgtcctcctcgcatctct-3' and reverse (5'-ggtgcgcaatacatctccag-3') primers. Th e nucleotide sequences of these primers correspond to sequences 297-316 and 551-532 of human IGF1 cDNA (GenBank accession number NM_000618). Th e amplifi cation of IGF2 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-caatggggaagtcgatgctg-3' and reverse -5'-ggaaacagcactcctcaacg-3'. Th e nucleotide sequences of these primers correspond to sequences 763-782 and 969-950 of human IGF2 cDNA (GenBank accession number NM_000612). For amplifi cation of IGF1R cDNA we used forward (5'-gccactactactatgccggt-3' and reverse (5'-gtgcatccttggagcatctg-3') primers. Th e nucleotide sequences of these primers correspond to sequences 875-856 and 1111-1092 of human IGF1R cDNA (GenBank accession number NM_000875). Th e amplifi cation of IGFBP4 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-caccccaacaacagcttcag-3' and reverse -5'-agttggggatggggatgatg-3'. Th e nucleotide sequences of these primers correspond to sequences 679-698 and 922-903 of human IGFBP4 cDNA (GenBank accession number NM_001552). For amplifi cation of STC2 cDNA we used two oligonucleotides primers: forward -5'-gttcatgaccctggctttgg-3' and reverse -5'-gcgtgggccttacatttcaa-3'. Th e nucleotide sequences of these primers correspond to sequences 1334-1353 and 1648-1629 of human STC2 cDNA (GenBank accession number NM_003714). Th e amplifi cation of ACTB (beta-actin) cDNA for real time RCR analysis was performed using forward -5'-ggacttcgagcaagagatgg-3' and reverse -5'-agcactgtgttggcgtacag-3' primers. Th ese primers nucleotide sequences correspond to 747-766 and 980-961 of human ACTB cDNA (GenBank accession number NM_001101). Th e expression of beta-actin mRNA was used as control of analyzed RNA quantity. Th e primers were received from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Quantitative PCR analysis was performed using a special computer program "Diff erential expression calculator" and statistical analysis -as described previously (Bochkov et al 2006) . Th e values of IGF1, IGF2, IGF1R, and IGFBP4 gene expressions were normalized to the expression of beta-actin mRNA and represent as percent of control (100%). All values are expressed as mean ± SEM from triplicate measurements performed in four independent experiments. Th e amplifi ed DNA fragments were also analyzed on a 2% agarose gel and that visualized by SYBR* Safe DNA Gel Stain (Life Technologies, Carlsbad, CA, U.S.A.).
Results
Inhibition of IRE1 aff ects the expression of IGF1, IGF2, IGF1R, IGFBP4 and STC2 genes in U87 glioma cells. To investigate a possible role of ER stress signaling mediated by IRE1 bifunctional enzyme in the expression level of IGFs, IGF1 receptor and IGF binding proteins 4 and 5 mRNA, we studied the effect of IRE1 inhibition by dnIRE1 on these genes expression in U87 glioma cells. As shown in Figure 1a , the expression level of IGF1 mRNA was signifi cantly down-regulated (2.3 times) in U87 glioma cells by inhibition of IRE1 signaling enzyme in comparison with the control cells. Th e expression level of IGF2 mRNA in glioma cells without IRE1 signaling enzyme function was also down-regulated (1.6 times) in comparison with the control glioma cells. Th e level of IGF2 protein was also signifi cantly decreased (Figure 1b) . At the same time, inhibition of IRE1 by dnIRE1 slightly but statistically signifi cantly up-regulated the expression level of IGF receptor (IGF1R) mRNA (+26%) in glioma cells in comparison with the control cells (Figure 1a) . We next investigated the expression of IGFBP4 gene in relation to the inhibition of IRE1 signaling enzyme function. As shown in Figure 1a , the expression level of this IGF binding protein-4 was strongly increased (3.8 times) in glioma cells with suppressed function of IRE1 signaling enzyme. More strong induction was shown for STC2 gene (6.1 times). Th us, the inhibition of ER stress signaling mediated by IRE1 enzyme aff ects the expression level of insulin-like growth factors, IGF receptor-1, IGF binding protein-4 and STC2 in genespecifi c manner.
Eff ect of hypoxia on the expression of IGF1, IGF2, IGF1R, IGFBP4, and STC2 genes in control glioma cells and cells without IRE1 enzyme function. We next investigated the eff ect of hypoxia on the expression of IGF1, IGF2, IGF1R, and IGFBP4 genes in glioma cells in relation to inhibition of IRE1 signaling enzyme function. We found that expression levels of IGF1 and IGF1R genes were resistant to hypoxia both in the control glioma cells and cells without IRE1 signaling enzyme function in comparison with corresponding controls (control 1 and 2) (Figure 2, Figure 4) . As shown in Figure 3 , hypoxia also did not change signifi cantly the expression level of IGF2 gene in control glioma cells in comparison with the control 1. At the same time, inhibition of IRE1 signaling enzyme introduced the sensitivity of IGF2 gene expression to hypoxia. Th us, in glioma cells without IRE1 signaling enzyme function the expression level of IGF2 gene was signifi cantly down-regulated (2.5 times) in comparison with corresponding control (control 2; Figure 3) .
As shown in Figure 5 , the expression level of IGFBP4 gene was strongly aff ected by inhibition of IRE1 signaling enzyme function in both control and IRE1 defi cient glioma cells. Th us, inhibition of IRE1 enzyme function by dnIRE1 strongly up-regulated the expression level of IGFBP4 mRNA (1.9 times) in control glioma cells and in 1.8 times in cells without IRE1 signaling enzyme function in comparison with corresponding controls (control 1 and control 2). Investigation of STC2 gene expression showed high sensitivity to hypoxia (Figure 6 ). Th us, in control glioma cells the expression level of STC2 gene was significantly up-regulated (7.0 times) in comparison with corresponding control (control 1) and slightly lesser induction of this gene expression (4.1 times) was observed in cells without IRE1 signaling enzyme function ( Figure 6 ).
Th us, the expression of IGF1 and IGF1R genes was resistant to hypoxia both in glioma cells with and without IRE1 signaling enzyme function, but IGFBP4, STC2, and IGF2 genes expression was sensitive to treatment cells by hypoxia: signifi cant up-regulation of IGFBP4 and STC2 genes and down-regulation of IGF2 gene, but only in cells without IRE1 function.
Moreover, eff ect of hypoxia on IGFBP4 gene expression did not depend on the inhibition of IRE1 signaling enzyme, but the expression of STC2 gene increased by hypoxia more signifi cantly in control glioma cells in comparison with cells without IRE1 function.
Discussion
Th e growing tumor requires the ER stress and hypoxia for own neovascularization and growth as well as for inhibition of apoptosis (Drogat et al. 2007; Auf et al. 2010 Auf et al. , 2013 Minchenko et al. 2015a) . Th e ER has an important position as a signal integrator both in normal and malignant cells because its stress signaling pathways is involved in numerous metabolic pathways (Bravo et al. 2013; Minchenko et al. 2013b; Manie et al. 2014; Pluquet et al. 2014) . It is known that the inhibition of the activity of IRE1 signaling Values of IGF1R mRNA expressions were normalized to beta-actin mRNA level and represent as percent for control 1 (100 %); n=4. enzyme in glioma cells had anti-tumor eff ects (Auf et al. 2010 (Auf et al. , 2013 Minchenko et al. 2014 Minchenko et al. , 2015c . In this work, we studied the expression of genes encoded different insulin-like growth factors, their receptor, and binding protein-4 as well as stanniocalcin-2, which responsible for stability of IFGBP4 and bioavailability of IGFs, in glioma cells with inhibition of IRE1 signaling enzyme function upon hypoxia. It is needed for evaluation of possible signifi cance of these genes in the control of glioma growth through ER stress signaling mediated by IRE1 and hypoxia.
Results of this study demonstrate that inhibition of IRE1 signaling enzyme function signifi cantly decreased the expression level of both IGF1 and IGF2 genes, indicating its participation in IRE1 mediated network of unfolded protein response. It is possible that decreased expression of IGF1 and IGF2 genes in glioma cells without enzymatic activity of IRE1 contributes to the suppression of proliferation and glioma growth from cells with IRE1 knockdown (Auf et al. 2010 (Auf et al. , 2013 Minchenko et al. 2015c) . Th ese results conform the view that IGF1 and IGF2 have mainly pro-proliferative functions through interaction with diff erent proteins and signaling pathways and are overexpressed in various malignant tumors (Pollak 2008; Halje et al. 2012; Panda et al. 2013; Baxter 2014) . We also showed that the expression level of IGF1R gene slightly increases upon inhibition of IRE1. It is possible that this increase in IGF1R gene expression level is a result of IGFs down-regulation as an emerging paradigm of insulin-like growth factor type 1 receptor signaling regulation (Girnita et al. 2014) . At the same time, IGF signaling system is over expressed in variety of cancer, especially in prostate and breast cancer, and inhibitors of IGF signaling have been subjected to clinical cancer trials with the main objective to confi rm the eff ectiveness of these receptors as a therapeutic target (Singh et al. 2014) . However, the results, which these trials produced, proved to be disappointing as the role played by the cross-talk between IGF and insulin receptor signaling pathways at the receptor level or at downstream signaling level became more lucid (Singh et al. 2014) .
Th e insulin-like growth factor binding proteins bind and regulate the availability of both IGFs with diff erent affi nity and inhibit or stimulate the growth promoting eff ects of the IGFs through IGF/insulin receptors and through many other signaling pathways and regulate cell proliferation and survival as well as cancer cell migration (Weroha and Haluska 2012; Baxter 2014; Pan et al. 2014; Singh et al. 2014) . In this study, we are showing that inhibition of IRE1 signaling, which is a central mediator of the unfolded protein response and an important component of malignant tumor growth, is strongly up-regulated the expression level of IGFBP4 gene in U87 glioma cells and that induction of this gene expression possibly contributes to suppression of IRE1 knockdown cell proliferation, because this protein negatively regulating IGF signaling and preferentially acts as a tumor suppressor (Praveen Kumar et al. 2014) . Recently it has been shown that inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP4, an important negative regulator of IGF-1 signaling, leading to reduced angiogenesis and melanoma growth (Contois et al. 2015) . It is interesting to note that adipose tissue expandability in response to high fat diet is associated with the IGFBP4 down-regulation (Gealekman et al. 2014) .
We also observed signifi cant up-regulation of STC2 gene expression in glioma cells aft er inhibition of IRE1 signaling, which protects IGFBP4 protein from degradation by proteolytic inhibition of the growthpromoting metalloproteinase, pregnancy-associated plasma protein-A (PAPP-A) (Jepsen et al. 2015) . Th us, up-regulation of the expression of these multifunctional proteins (STC2 and IGFBP4) in glioma cells aft er inhibition of IRE1 can contribute to the suppression of these glioma cells proliferation, because IGFBP4 protein negatively regulating IGF signaling (Praveen Kumar et al. 2014; Contois et al. 2015) .
Our data demonstrate that all of the genes studied are ER stress responsive and consequently play a pivotal role in the control of cell proliferation as well as metastasis. However, the mechanisms of activation or suppression of these genes expression upon inhibition of IRE1 diff ers and warrant further studies.
Th e investigation of hypoxic regulation of the expression of diff erent IGFs and related genes in glioma cells in respect to inhibition of IRE1 signaling is very important for understanding of malignant tumor growth mechanisms, because low oxygen has essential role in the control of proliferation as that tumor progression (Lenihan and Taylor 2013; Minchenko et al. 2013a Minchenko et al. , 2015a . We showed that hypoxia leads to up-regulation of the expression of IGFBP4 and STC2 genes in both types of used glioma cells and downregulation of IGF2 gene but only in glioma cells with inhibited IRE1 activity. Th is down-regulation of IGF2 gene expression is correlated well with anti-proliferative eff ect of IRE1 inhibition; however, the functional signifi cance of up-regulation of IGFBP4 as well as STC2 gene expression is not clear yet (Figure 7) and warrants further investigation. At the same time, the expression of IGF1 and IGF1R genes was resistant to hypoxic exposure in both types of glioma cells (control and IRE1 knockdown). Th us, inhibition of IRE1 modifi es the sensitivity of some studied genes expression to hypoxia and induces negative eff ect of IRE1 inhibition on IGF2 gene expression as well as reduces eff ect of hypoxia on the expression of STC2 gene in glioma cells. At the same time, eff ect of hypoxia on the expression of IGFBP4 gene is not modifi ed by inhibition of IRE1 enzyme in U87 glioma cells.
Th is study provides unique insights into the molecular mechanisms regulating the expression of genes encoded insulin-like growth factors and some related proteins and their correlation with slower cell proliferation in cells harboring dnIRE1, attesting to the fact that endoplasmic reticulum stress is a necessary component of malignant tumor growth, cell survival and metastasis. Moreover, the expression of some studied genes upon hypoxia is signifi cantly depended on the IRE1 signaling enzyme function; however, the detailed molecular mechanisms of this regulation are complex yet and warrants further studies.
